Log in

239 Pak Fah Yeow International Limited HKEX · Hong Kong

Pak Fah Yeow International (239) news

Pak Fah Yeow International Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 239, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Pak Fah Yeow International news

We have not published a story on Pak Fah Yeow International yet. When there is news, it will appear here.

Questions about Pak Fah Yeow International

What is the ticker symbol of Pak Fah Yeow International?

Pak Fah Yeow International Limited trades under the ticker 239 on HKEX.

Where is Pak Fah Yeow International listed?

Pak Fah Yeow International Limited is listed on HKEX.

Which country or territory is Pak Fah Yeow International listed under?

Our directory records Pak Fah Yeow International Limited under Hong Kong.

What does Pak Fah Yeow International do?

Our directory classifies Pak Fah Yeow International Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Pak Fah Yeow International?

The ISIN recorded for Pak Fah Yeow International Limited is BMG6873Y1176.

Does aibio.space cover Pak Fah Yeow International?

aibio.space lists Pak Fah Yeow International Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Pak Fah Yeow International?

Companies in our directory listed in the same country and business area as Pak Fah Yeow International: Grand Pharmaceutical Group, Beijing Tong Ren Tang Chinese Medicine Co., InSilico Medicine Cayman TopCo, Lee's Pharmaceutical Holdings, Shenzhen Neptunus Interlong Bio-Technique Co., SSY Group.

Investor discussion: Pak Fah Yeow International

Members talk about Pak Fah Yeow International (239). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Pak Fah Yeow International, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND REAPPOINTMENT OF AUDITOR AND AMENDMENTS TO EXISTING BYE-LAWS AND NOTICE OF ANNUAL GENERAL MEETING. Source

  2. Financings

    Share or debt issue: PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of Pak Fah Yeow International's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    Notification Letter to Non-registered Shareholders and Request Form

  2. HKEXnews

    Notification Letter to Registered Shareholders and Change Request Form

  3. HKEXnews

    Special Interim Dividend for the six months ended 30 June 2026 and Closure of Register of Members

  4. HKEXnews

    Interim Dividend for the six months ended 30 June 2026 and Closure of Register of Members

  5. HKEXnews

    INTERIM DIVIDENDS FOR 2026 CLOSURE OF REGISTER OF MEMBERS

  6. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  7. HKEXnews

    POSITIVE PROFIT ALERT

  8. HKEXnews

    VOLUNTARY ANNOUNCEMENT CHANGE OF SHAREHOLDING STRUCTURE IN A SUBSTANTIAL SHAREHOLDER

  9. HKEXnews

    Memorandum of Association and Bye-laws (as amended by special resolution passed on 2 June 2026)

  10. HKEXnews

    POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 2 JUNE 2026

  11. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  12. HKEXnews

    PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND REAPPOINTMENT OF AUDITOR AND AMENDMENTS TO EXISTING BYE-LAWS AND NOTICE OF ANNUAL GENERAL MEETING

  13. HKEXnews

    PROPOSED AMENDMENTS TO THE EXISTING BYE-LAWS

  14. HKEXnews

    Special Final Dividend for the year ended 31 December 2025

  15. HKEXnews

    Final Dividend for the year ended 31 December 2025

  16. HKEXnews

    FINAL DIVIDEND AND SPECIAL FINAL DIVIDEND CLOSURE OF REGISTER OF MEMBERS

  17. HKEXnews

    ANNOUNCEMENT OF ANNUAL RESULTS 2025

  18. HKEXnews

    Special Interim Dividend for the six months ended 30 June 2025 and Closure of Register of Members

  19. HKEXnews

    Interim Dividend for the six months ended 30 June 2025 and Closure of Register of Members

  20. HKEXnews

    INTERIM DIVIDENDS FOR 2025 CLOSURE OF REGISTER OF MEMBERS

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:239 on TradingView.

Listing details

Pak Fah Yeow International Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 239, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Pak Fah Yeow International Limited
Ticker
239
Listing
HKEX
Country or territory
Hong Kong
Business scope
Pharmaceuticals: Major
ISIN
BMG6873Y1176
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.